BioVie Inc. Struggles Amid Nasdaq Volatility as It Pursues Liver Cirrhosis Therapies
BioVie Inc., a biotech company focused on developing therapies for liver cirrhosis complications, faces financial challenges and market volatility despite its efforts to address a significant global health concern.
2 minutes to read